Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

NICE backpedals on decision to limit access to Roche's Tarceva

04.04.2014 / Scripintelligence

NICE has made a U-turn on its decision to restrict the use of Roche's Tarceva (erlotinib) in second-line non-small cell lung cancer (NSCLC).

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: